TSN-084

N/A

Report date: 2023/04/06 17:17:04
NME

Base Information

Drug NameTSN-084
Drug Alias NameTSN-084
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 8 inhibitorsCyclin-dependent kinase 19 inhibitors
TargetsCyclin-dependent kinase 8Cyclin-dependent kinase 19
Therapy Area/IndicationsNeoplasm MetastasisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTyligand Bioscience (Shanghai) Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTyligand Bioscience (Shanghai) Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasm Metastasis
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A